p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab

Mounting evidence supports the role of p53 in metabolic processes involved in breast carcinogenesis. We investigated whether p53 status affects the association of pre-treatment fasting glucose with treatment outcomes in 106 non diabetic, HER2 positive breast cancer patients treated with trastuzumab....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Vici, Patrizia, Sperati, Francesca, Maugeri-Saccà, Marcello, Melucci, Elisa, Benedetto, Anna Di, Lauro, Luigi Di, Pizzuti, Laura, Sergi, Domenico, Terrenato, Irene, Esposito, Luca, Iannuzzi, Carmelina Antonella, Pasquale, Raffaella, Botti, Claudio, Fuhrman, Barbara, Giordano, Antonio, Mottolese, Marcella, Barba, Maddalena
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279380/
https://ncbi.nlm.nih.gov/pubmed/25071015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados